Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENFORTUMAB VEDOTIN Cause Dyspnoea? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Dyspnoea have been filed in association with ENFORTUMAB VEDOTIN (PADCEV EJFV). This represents 1.8% of all adverse event reports for ENFORTUMAB VEDOTIN.

26
Reports of Dyspnoea with ENFORTUMAB VEDOTIN
1.8%
of all ENFORTUMAB VEDOTIN reports
6
Deaths
20
Hospitalizations

How Dangerous Is Dyspnoea From ENFORTUMAB VEDOTIN?

Of the 26 reports, 6 (23.1%) resulted in death, 20 (76.9%) required hospitalization, and 1 (3.8%) were considered life-threatening.

Is Dyspnoea Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENFORTUMAB VEDOTIN. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does ENFORTUMAB VEDOTIN Cause?

Rash (173) Neuropathy peripheral (172) Malignant neoplasm progression (166) Decreased appetite (106) Diarrhoea (96) Pruritus (83) Alopecia (78) Inappropriate schedule of product administration (73) Pyrexia (70) Hyperglycaemia (69)

What Other Drugs Cause Dyspnoea?

ALBUTEROL (21,856) TREPROSTINIL (16,348) AMBRISENTAN (13,367) PREDNISONE (12,830) BUDESONIDE\FORMOTEROL (11,158) TIOTROPIUM (10,863) ADALIMUMAB (10,547) DUPILUMAB (10,310) FLUTICASONE\SALMETEROL (9,783) MEPOLIZUMAB (9,192)

Which ENFORTUMAB VEDOTIN Alternatives Have Lower Dyspnoea Risk?

ENFORTUMAB VEDOTIN vs ENFORTUMAB VEDOTIN-EJFV ENFORTUMAB VEDOTIN vs ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV ENFORTUMAB VEDOTIN vs ENFUVIRTIDE ENFORTUMAB VEDOTIN vs ENOXAPARIN ENFORTUMAB VEDOTIN vs ENOXAPARIN - WINTHROP

Related Pages

ENFORTUMAB VEDOTIN Full Profile All Dyspnoea Reports All Drugs Causing Dyspnoea ENFORTUMAB VEDOTIN Demographics